Pediatric Pharmacokinetics Human Development and Drug Disposition

被引:35
|
作者
Funk, Ryan S. [1 ]
Brown, Jacob T. [1 ]
Abdel-Rahman, Susan M. [1 ,2 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Pediat, Sch Med, Kansas City, MO 64108 USA
关键词
Pediatric; Pharmacokinetic; Development; Absorption; Distribution; Metabolism; Excretion; Transport; SINGLE-DOSE PHARMACOKINETICS; PLASMA-PROTEIN BINDING; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION; HUMAN LIVER; POPULATION PHARMACOKINETICS; INTRAVENOUS OMEPRAZOLE; HEALTHY-VOLUNTEERS; PRETERM INFANTS; SMALL-INTESTINE;
D O I
10.1016/j.pcl.2012.07.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
引用
收藏
页码:1001 / +
页数:17
相关论文
共 50 条
  • [1] A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development
    Di, Li
    Feng, Bo
    Goosen, Theunis C.
    Lai, Yurong
    Steyn, Stefanus J.
    Varma, Manthena V.
    Obach, R. Scott
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 1975 - 1993
  • [2] Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
    Mooij, Miriam G.
    Nies, Anne T.
    Knibbe, Catherijne A. J.
    Schaeffeler, Elke
    Tibboel, Dick
    Schwab, Matthias
    de Wildt, Saskia N.
    CLINICAL PHARMACOKINETICS, 2016, 55 (05) : 507 - 524
  • [3] Alterations in drug disposition in older adults
    Reeve, Emily
    Wiese, Michael D.
    Mangoni, Arduino A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (04) : 491 - 508
  • [4] Drug metabolism and pharmacokinetics
    Benedetti, Margherita Strolin
    Whomsley, Rhys
    Poggesi, Italo
    Cawello, Willi
    Mathy, Francois-Xavier
    Delporte, Marie-Laure
    Papeleu, Peggy
    Watelet, Jean-Baptiste
    DRUG METABOLISM REVIEWS, 2009, 41 (03) : 344 - 390
  • [5] Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans
    Xu, Donghong
    Divanji, Punag
    Griffith, Adrienne
    Sukhun, Rajaa
    Cheplo, Kathleen
    Li, Jianlin
    German, Polina
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (05):
  • [6] Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing
    Kendrick, Jennifer G.
    Carr, Roxane R.
    Ensom, Mary H. H.
    CLINICAL THERAPEUTICS, 2015, 37 (09) : 1897 - 1923
  • [7] Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development
    Wu, Xiaojie
    Meng, Jian
    Yuan, Hong
    Zhong, Dafang
    Yu, Jicheng
    Cao, Guoying
    Liu, Xingdang
    Guo, Beining
    Chen, Yuancheng
    Li, Yi
    Shi, Yaoguo
    Gordeev, Mikhail F.
    Wu, Jufang
    Zhang, Jing
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (11)
  • [8] Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics
    Gao, Yu
    Shao, Jingwei
    Jiang, Zhou
    Chen, Jianzhong
    Gu, Songen
    Yu, Suhong
    Zheng, Ke
    Jia, Lee
    DRUG DISCOVERY TODAY, 2014, 19 (03) : 326 - 340
  • [9] Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species
    Chen-chun Zhong
    Feng Chen
    Jun-ling Yang
    Wei-wei Jia
    Li Li
    Chen Cheng
    Fei-fei Du
    Su-ping Zhang
    Cheng-ying Xie
    Na-ting Zhang
    Olajide E Olaleye
    Feng-qing Wang
    Fang Xu
    Li-guang Lou
    Dong-ying Chen
    Wei Niu
    Chuan Li
    Acta Pharmacologica Sinica, 2018, 39 : 1048 - 1063
  • [10] Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species
    Zhong, Chen-chun
    Chen, Feng
    Yang, Jun-ling
    Jia, Wei-wei
    Li, Li
    Cheng, Chen
    Du, Fei-fei
    Zhang, Su-ping
    Xie, Cheng-ying
    Zhang, Na-ting
    Olaleye, Olajide E.
    Wang, Feng-qing
    Xu, Fang
    Lou, Li-guang
    Chen, Dong-ying
    Niu, Wei
    Li, Chuan
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (06) : 1048 - 1063